Centauri Therapeutics Limited
Centauri Therapeutics is an immunotherapy company that focuses on addressing life-threatening infectious diseases, particularly in vulnerable patients. Their Alphamer® technology redirects naturally existing antibodies to treat these diseases.
- Alphamer® technology
- Immunotherapy for infectious diseases
Locations
Digital Popularity
Social Media
Competitors
Micregen is a pioneering biotechnology company focused on developing innovative stem cell-derived secretome therapies to address age-related conditions.
Company Details
Centauri Therapeutics Limited is operated by Centauri Therapeutics Limited and is a Active company incorporated on 6 February 2014 with the registered office located in London, City of London. Centauri Therapeutics Limited was registered 11 years ago.
Status
Active
Size
Small
Directors
7
Age
11 years old
Employees
12
Turnover
Unreported
Total Assets
£7.03M
Cash in Bank
£5.1M
Total Liabilities
-£324K
Teams
15
9
7
3
Vice President Operations • Joined Jul 2022
Chief Executive Officer • Joined May 2022
Chief Scientific Officer • Joined Nov 2023
Director • Joined Mar 2015
Product Development Lead • Joined Jan 2024
Office Manager
Office Manager
Head Of Biology • Joined Sep 2023
Head Of Chemistry • Joined Feb 2022
Associate Scientist • Joined Oct 2023
Vice President Operations • Joined Jul 2022
Chief Executive Officer • Joined May 2022
Chief Scientific Officer • Joined Nov 2023
Director • Joined Mar 2015
Product Development Lead • Joined Jan 2024
Office Manager
Office Manager
Scientist • Joined Jul 2024
Senior Immunologist • Joined Jul 2022
Chief Scientific Officer • Joined Nov 2023
Head Of Biology • Joined Sep 2023
Head Of Chemistry • Joined Feb 2022
Associate Scientist • Joined Oct 2023
Associate Scientist II • Joined Jul 2024
Senior Microbiologist • Joined Oct 2023
Scientist • Joined Jul 2024
Office Manager
Office Manager
Adminstrative Assistant
View 15 members